CNBC Daily Open: Generic problems, AI valuations and earnings on tapSkip NavigationMarketsPre-MarketsU.S.
MarketsCurrenciesPrediction MarketsCryptocurrencyFutures & CommoditiesBondsFunds &
ETFsBusinessEconomyFinanceHealth & ScienceMediaReal
EstateEnergyClimateTransportationInvestigationsIndustrialsRetailWealthSportsLifeSmall BusinessInvestingPersonal
FinanceFintechFinancial AdvisorsOptions ActionETF StreetBuffett ArchiveEarningsTrader
TalkTechCybersecurityAIEnterpriseInternetMediaMobileSocial MediaCNBC Disruptor 50Tech GuidePoliticsWhite
HousePolicyDefenseCongressExpanding OpportunityVideoLatest VideoFull EpisodesLivestreamLive AudioLive TV ScheduleCNBC
PodcastsCEO InterviewsCNBC DocumentariesDigital OriginalsWatchlistInvesting ClubTrust PortfolioAnalysisTrade
AlertsMeeting VideosHomestretchJim's ColumnsEducationSubscribePROPro NewsJosh BrownMike SantoliCalls of the DayMy
PortfolioLivestreamFull EpisodesStock ScreenerMarket ForecastOptions InvestingChart InvestingSubscribeLivestreamMenuMake
ItselectUSAINTLLivestreamSearch quotes, news & videosLivestreamWatchlistSIGN INCreate free
accountMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenuDaily OpenCNBC Daily Open:
Generic problems, AI valuations and earnings on tapPublished Wed, Jul 22 20262:22 AM EDTLeonie KiddWATCH LIVEKey
PointsPresident Donald Trump proposes 100% tariffs on generic pharmaceuticals from 2028. U.S. and China are expected to
hold AI talks ahead of Trump's meeting with China's Xi Jinping in September. Treasury Secretary Scott Bessent
says the U.S. could sanction China over AI model "theft."Samsung reportedly eyes another investment in
MistralAI, valuing the French group at 20 billion euros ($22.82 billion).Secretary of State Marco Rubio says Iran is not
serious about peace talks. Earnings today: Alphabet and Tesla report after the bell.In this articleAIR-FRBASSNLFFollow
your favorite stocksCREATE FREE ACCOUNTAn employee monitors bottles as they move along the drug production line inside
the packaging unit at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India,Bloomberg | Bloomberg | Getty
ImagesHello, this is Leonie Kidd coming to you from London. A busy day for investors with a fresh tariff threat from the
White House, more moving and shaking in the AI space, tension in Iran and another massive set of earnings on Wall
Street. Read on!What you need to know todayPresident Donald Trump says the United States will raise tariffs on generic
drugs to 100% in 2028, and 200% thereafter. Taking to Truth Social, he explained: "This is done in order to RESHORE
Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and
Equipment within the stated period of time given to them." The stakes are high for India, as the country's
pharmaceutical companies supply nearly 50% of all generic medicines consumed in America. All about AIThe U.S. and
China are reportedly set to hold AI talks in September, ahead of Chinese President Xi Jinping's visit to the White
House later that month. This comes as U.S. Treasury Secretary Scott Bessent said the Trump administration will look into
whether Chinese AI models have been distilled from American models.Speaking to Fox News, he said: "If we see,
especially that overseas models are stealing from our great companies, we have the ability to sanction them because of
this theft."Meanwhile, Samsung is reportedly considering a fresh investment in French AI darling Mistral. According
to the Financial Times, the South Korean group could inject 1 billion euros ($1.14 billion) in the new round, valuing
Mistral at around 20 billion euros. Samsung declined to comment on the report, while Mistral had yet to respond.
'They're not serious'U.S. Secretary of State Marco Rubio has said Iran is not taking peace talks
seriously. Speaking at the ASEAN Foreign Ministers' meeting in the Philippines, he said: "The problem
we're having right now is that they're not serious about talks. If they're serious, we're serious.
If they're not, then we will do what is necessary to protect our interest and also the interest of our
allies."These comments come as U.S. forces struck targets in Iran for an 11th straight night, with Central Command
seeking to "continue degrading Iran's ability to threaten commercial shipping in the Strait of
Hormuz."Wednesday's big stock storiesInvestors will look to cut through the geopolitical noise on a busy
earnings day, particularly for Wall Street, where giants Alphabet and Tesla will report after the bell. Futures are
holding steady ahead of those releases. Google and YouTube parent Alphabet has risen 4.5.% in the last three months, but
the stock is 15% off its May highs. Meanwhile, options traders are betting Tesla could see its biggest post-earnings
move in a year when the electric auto giant reports on Wednesday.— Leonie KiddAnd Finally...These Japanese AI winners
don’t make chips. They make toilets, glass fiber and seasoningAt a time when investor attention has been on the
semiconductor industry, some hidden gems with businesses quite dissimilar to high tech have turned out to be market
winners, riding the AI boom.Toto is best known for high-end toilets, Nittobo makes textiles and glass fiber, and
Ajinomoto makes MSG seasoning. Their shares have gained 78%, 63% and 61%, respectively, this year, as they make use of
their core technologies to benefit from the AI supply chain.— Lim Hui JieChoose CNBC as your preferred source on
Google and never miss a moment from the most trusted name in business news.More In Daily OpenCNBC Daily Open: Spending
shock disappoints Wall StreetLeonie Kidd17 min agoCNBC Daily Open: Trump ratchets up war rhetoric, Houthis target Red
Sea Lim Hui Jie5 hours agoCNBC Daily Open: AI race, potential tariffs and Middle East conflict continue to heat up
Justina LeeRead MoreSubscribe to CNBC PROSubscribe to Investing ClubLicensing & ReprintsCNBC CouncilsSelect Personal
FinanceJoin the CNBC PanelClosed CaptioningDigital ProductsNews ReleasesInternshipsCorrectionsAbout CNBCSite
MapPodcastsCareersHelpContactNews TipsGot a confidential news tip? We want to hear from you.Get In TouchCNBC
NewslettersSign up for free newsletters and get more CNBC delivered to your inboxSign Up NowGet this delivered to your
inbox, and more info about our products and services.Advertise With UsPlease Contact UsAd ChoicesPrivacy PolicyYour
Privacy ChoicesCA NoticeTerms of Service© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company. Data
is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and
Market Data and Analysis. Market Data Terms of Use and DisclaimersData also provided by